The degree of bladder wall invasion by bladder cancer determines the clinical management, for muscle invasive bladder cancer (MIBC, Stage T2 or more) recommended neoadjuvant chemotherapy before radical cystectomy and non-muscle invasive bladder cancer (NMIBC, Stage T1 or lower) treated with transurethral resection (TUR). Thus, differentiating NMIBC from MIBC using preoperative imaging plays a crucial role in clinical practice.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords